#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anti-HLA antibody test positive Vaginal cancer Renal cancer metastatic Glomerulonephritis minimal lesion Systemic lupus erythematosus Osteosarcoma Nephrotic syndrome Thrombocytopenia Microscopic polyangiitis Mitochondrial encephalomyopathy Hypergammaglobulinaemia benign monoclonal Dermatomyositis Autologous haematopoietic stem cell transplant Neonatal alloimmune thrombocytopenia Non-Hodgkin's lymphoma refractory More trials…

    Learn about Rare Diseases

    Primary mediastinal large B-cell lymphoma Amyotrophic lateral sclerosis – Basic Information Marginal zone lymphoma – Basic Information Mantle cell lymphoma refractory – Basic Information Hereditary optic atrophy Proteus syndrome – Diagnostics Pulmonary fibrosis Medulloblastoma – Basic Information Rosai-Dorfman syndrome Adrenocortical carcinoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Serine Vindesine Sulfate Pertuzumab Lasmiditan Gadoteridol Dexlansoprazole ACT-1004-1239 Frexalimab Gad20-209-Fsp-A1 Tak-280 Clobetasol Propionate Ltx-315 Sodium Oxybate Betahistine Dihydrochloride Tadekinig Alfa Imipenem Monohydrate TORASEMIDE Raltegravir Pentosan Polysulfate Sodium Nazartinib More therapies…

    Learn about Your Condition

    BRAF gene mutation Crohn's disease Tubulointerstitial nephritis Pneumococcal infection Hyperchylomicronaemia Soft tissue sarcoma Epilepsy Epiphysiolysis Liver disorder Immunodeficiency Alcohol use disorder Malignant melanoma of eyelid Dyslipidaemia Urea cycle disorder Lysosomal storage disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effectiveness of Adding Progesterone to Chemotherapy with Etoposide, Doxorubicin, Cisplatin, and Mitotane for Advanced Adrenocortical Carcinoma Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Adrenocortical carcinoma
    Investigated Drugs:
    • MEGESTROL ACETATE
    • Mitotane
    • Cisplatin
    Italy

  • Study of Atezolizumab, Carboplatin, and Nab-Paclitaxel for Patients with Metastatic Triple-Negative PD-L1 Positive Breast Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Atezolizumab
    • Carboplatin
    • Paclitaxel Albumin-Bound
    Italy

  • Study on the Effects of Amoxicillin on Post-Surgical Complications in Patients with Tooth Loss Undergoing Implant Surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Post procedural complication
    Investigated Drugs:
    • Amoxicillin
    Spain

  • Study on the Effects of Inhaled Treprostinil for Patients with Progressive Pulmonary Fibrosis

    Recruiting

    3 1
    Investigated Drugs:
    • Treprostinil
    Belgium France Germany Italy Spain

  • Study comparing oxaliplatin and irinotecan chemotherapy effectiveness using tumor testing in patients with metastatic colorectal cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Irinotecan Hydrochloride Trihydrate
    • Oxaliplatin
    Norway

  • Study on Long-term Safety of XTMAB-16 for Patients with Pulmonary Sarcoidosis with or without Extra-pulmonary Involvement

    Recruiting

    2 1 1
    Investigated Drugs:
    • Xtmab-16
    Czechia Denmark Italy Poland Spain
Previous Page
1 … 280 281 282 283 284 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!